Zadnji put ažurirano :
19/11/2024
istraživačkih timova - Novartis, Menges, Slovenia   pdf  
Slovenija
Farmaceutski laboratorij
Novartis, Menges, Slovenia
Menges
Bibliografija   Bibliografija   (2)  
1
Study of the Stability of Sandoz Rituximab Biosimilar Rixathon®/Riximyo® When Subjected for up to 21 Days to Ambient Storage.
Borišek R, Mischo A, Šmid I. (roman.borisek@novartis.com)
Drugs R D - 2022 - ; 22,3: 225–234
2
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion.
Vimpolsek M, Gottar-Guillier M, Rossy E. (maja.vimpolsek@novartis.com)
Drugs R D - 2019 - 19: 127–140.

Liste   molekule studirao   (2)  
imunosupresori injekcija Infliximab
lijek protiv karcinoma injekcija Rituximab

  Mentions Légales